MX9602442A - Un tratamiento con fluoroquinolona a dosis unica elevada. - Google Patents

Un tratamiento con fluoroquinolona a dosis unica elevada.

Info

Publication number
MX9602442A
MX9602442A MX9602442A MX9602442A MX9602442A MX 9602442 A MX9602442 A MX 9602442A MX 9602442 A MX9602442 A MX 9602442A MX 9602442 A MX9602442 A MX 9602442A MX 9602442 A MX9602442 A MX 9602442A
Authority
MX
Mexico
Prior art keywords
treatment
high dose
fluroquinolone
single high
fluoroquinolones
Prior art date
Application number
MX9602442A
Other languages
English (en)
Inventor
Dennis D Copeland
Kathleen W Ewert
Terry S Wollen
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23971311&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9602442(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of MX9602442A publication Critical patent/MX9602442A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)

Abstract

La presente invencion se relaciona con el tratamiento de animales con fluoroquinolonas. Más concretamente, la presente invencion se relaciona con el uso de fluoroquinolonas en una unica dosis elevada para substituir a las dosis inferiores multiples.
MX9602442A 1995-06-27 1996-06-21 Un tratamiento con fluoroquinolona a dosis unica elevada. MX9602442A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49611795A 1995-06-27 1995-06-27

Publications (1)

Publication Number Publication Date
MX9602442A true MX9602442A (es) 1997-02-28

Family

ID=23971311

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9602442A MX9602442A (es) 1995-06-27 1996-06-21 Un tratamiento con fluoroquinolona a dosis unica elevada.

Country Status (3)

Country Link
US (1) US5756506A (es)
CA (1) CA2176298C (es)
MX (1) MX9602442A (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1223935E (pt) * 1999-06-29 2008-04-03 Lg Life Sciences Ltd Utilização de compostos de gemifloxacina contra bactérias
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
US20050032813A1 (en) * 1999-09-14 2005-02-10 Jacques Dubois Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
US6872723B2 (en) * 2002-01-28 2005-03-29 Wyeth Stabilized difloxacin injectable solution
US7439268B2 (en) 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
DE102004054873A1 (de) * 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
WO2006061155A2 (de) * 2004-12-09 2006-06-15 Bayer Healthcare Ag Stabilisierung von glucocorticoidestern mit säuren
US7838532B2 (en) * 2005-05-18 2010-11-23 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US8524735B2 (en) * 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
WO2009154840A2 (en) * 2008-03-27 2009-12-23 Neostem, Inc. Compositions and methods using stem cells in cutaneous wound healing
US20100029662A1 (en) * 2008-08-01 2010-02-04 Alpha Synergy Development, Inc. Vasoconstriction compositions and methods of use
PL2344129T3 (pl) 2008-10-07 2018-07-31 Horizon Orphan Llc Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
JP2012505222A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 肺炎症を低減するためのレボフロキサシンの吸入
ES2739979T3 (es) 2009-09-04 2020-02-05 Horizon Orphan Llc Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670444B1 (en) * 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
DE3420116A1 (de) * 1984-05-30 1985-12-05 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel

Also Published As

Publication number Publication date
CA2176298A1 (en) 1996-12-28
US5756506A (en) 1998-05-26
CA2176298C (en) 2009-01-27

Similar Documents

Publication Publication Date Title
MX9602442A (es) Un tratamiento con fluoroquinolona a dosis unica elevada.
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
TW376320B (en) Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
WO1994027589A3 (en) Antidepressant dosage form
AU2293888A (en) Dosage form for treating cardiovascular diseases
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
HUP9801526A3 (en) Metered dose inhaler
HUP9802278A3 (en) Metered dose inhaler
EP0644946A4 (en) VECTOR PARTICLES RESISTANT TO HUMAN SERUM INACTIVATION.
IL136503A0 (en) Adamantane derivatives
IL136369A0 (en) Adamantane derivatives
GB8924823D0 (en) Dosage inhalers
FI970747A (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
ES8801243A1 (es) Procedimiento para la obtencion de medicamentos que contienen 1-heteroaril-4--aril-pirazolin-5-onas.
NZ211925A (en) Kit for use in treatment of osteoporosis including a polyphosphonate
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
GB2217598B (en) Solid, rapidly disintegrating dosage form comprising diclofenac
GB2274777B (en) Synergistic combination of compounds having an antagonist effect on nk1 and on nk2 receptors
HK1014498A1 (en) Bpi-protein-products for depressed reticuloendothelial system function.
MY111718A (en) Deuterated active substances in transdermal application
BG105275A (en) Tan-1057 derivatives
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
AU4361996A (en) The use of inositoltrisphosphate for the preparing of medicaments
IL101163A (en) Use of flunarizine in the preparation of medicaments for treating neoplastic diseases
MX9709013A (es) Forma de dosis que comprende oxibutinina.